Psilocybin-Research.comSearchable psilocybin and psilocin bibliometric database.Researcher index
Authors in the psilocybin and psilocin literature
Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.
Publication history
From trial to clinic: psilocybin's efficacy in routine treatment-resistant depression.The Lancet regional health. Europe · 2026-08-01C29-12 Psilocybin Treatment Could Improve Outcomes for Age-associated Lung DiseasesAmerican Journal of Respiratory and Critical Care Medicine · 2026-05-01Compassionate use of psilocybin for treatment-resistant depression in Germany.The lancet. Psychiatry · 2026-02-01Psilocybin treatment extends cellular lifespan and improves survival of aged mice.npj aging · 2025-07-08The Psychedelic Renaissance: A Catholic PerspectiveThe Linacre Quarterly · 2024-09-14Developing a Direct Observation Measure of Therapeutic Connection in Psilocybin-Assisted Therapy: A Feasibility Study.Journal of palliative medicine · 2023-12-01Psilocybin decelerates cellular senescenceResearch Square · 2023-06-27Psilocin suppresses methamphetamine-induced hyperlocomotion and acquisition of conditioned place preference via D2R-mediated ERK signalingCNS Neuroscience & Therapeutics · 2023-03-01The therapeutic potential of psychedelics: the European regulatory perspectiveThe Lancet · 2023-02-10Structure-based discovery of nonhallucinogenic psychedelic analogs.Science (New York, N.Y.) · 2022-01-28Denver votes to decriminalise psilocybin mushrooms.Lancet (London, England) · 2019-05-18Serotonergic hallucinogens in the treatment of anxiety and depression in patients suffering from a life-threatening disease: A systematic review.Progress in neuro-psychopharmacology & biological psychiatry · 2018-02-02[Psychotherapy with Adjuvant use of Serotonergic Psychoactive Substances: Possibilities and Challenges].Fortschritte der Neurologie-Psychiatrie · 2017-07-01Psilocybin: panacea or placebo?The lancet. Psychiatry · 2016-09-01Question-based Drug Development for psilocybin.The lancet. Psychiatry · 2016-09-01Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study.The lancet. Psychiatry · 2016-07-01Altered states: psilocybin for treatment-resistant depression.The lancet. Psychiatry · 2016-07-01Novel psychopharmacological therapies for psychiatric disorders: psilocybin and MDMA.The lancet. Psychiatry · 2016-05-01Turn on and tune in to evidence-based psychedelic researchThe Lancet Psychiatry · 2014-12-31[Hallucinogen-induced psychological disorders].Fortschritte der Neurologie-Psychiatrie · 2008-06-01Hallucinogen research inspires “neurotheology”The Lancet Neurology · 2006-08-17SAR of Psilocybin Analogues: Discovery of a Selective 5-HT2C Agonist.ChemInform · 2005-12-13Neurometabolic effects of psilocybin, 3,4-methylenedioxyethylamphetamine (MDE) and d-methamphetamine in healthy volunteers. A double-blind, placebo-controlled PET study with [18F]FDG.Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology · 1999-06-01Psychopathological, neuroendocrine and autonomic effects of 3,4-methylenedioxyethylamphetamine (MDE), psilocybin and d-methamphetamine in healthy volunteers. Results of an experimental double-blind placebo-controlled study.Psychopharmacology · 1999-02-01Increased activation of indirect semantic associations under psilocybin.Biological psychiatry · 1996-06-15[Psychedelic experiences at the onset of productive episodes of endogenous psychoses].Der Nervenarzt · 1994-03-01